Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age65+
SponsorCase Comprehensive Cancer Center
About this trial
The purpose of this study is to see whether participants who are assigned to a multimodal prehabilitation intervention during chemotherapy are able to adhere with exercise and nutrition program to prepare for their cancer surgery.
Eligibility criteria
Qualifiers
Age 65 and older
Patients with diagnosis of advanced (Stage III or IV) epithelial ovarian, fallopian tube, or
Patients with diagnosis of pancreatic adenocarcinoma (PDAC) (Stage I, II, or III) undergoing neoadjuvant chemotherapy.
Patients with locally advanced esophageal cancer undergoing neoadjuvant chemotherapy.
Disqualifiers
Life expectancy less than 3 months in the opinion of the treating physician
Patients unable to provide informed consent.
Wheelchair bound patients/ physical immobility.
Severe cardiopulmonary disease defined as NYHA class III or IV
Trial design
Treatments tested in this trial
- Prehabilitation
Treatment groups
22 Participants
are divided into 2 treatment groupsLocations
1Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center44195, ClevelandOhio, United States
Sponsors and collaborators
Case Comprehensive Cancer Center
Lead sponsor
Source ClinicalTrials.gov